Expert Consensus on the Incorporation of Anti-CD38 Monoclonal Antibody Therapy Into the Management of Newly Diagnosed Multiple Myeloma

CONCLUSIONS: The goal of the present review article is to encapsulate these consensus statements and the rationale for their development, which altogether may help inform treatment selection and clinical decision-making in the front line.PMID:37516547 | DOI:10.1016/j.clml.2023.07.001
Source: Clinical Lymphoma and Myeloma - Category: Cancer & Oncology Authors: Source Type: research